Type 2 Diabetes and Cancer: An Umbrella Review of Observational and Mendelian Randomization Studies.

Authors:
Pearson-Stuttard J; Papadimitriou N; Markozannes G; Cividini S; Kakourou A and 7 more

Journal:
Cancer Epidemiol Biomarkers Prev

Publication Year: 2021

DOI:
10.1158/1055-9965.EPI-20-1245

PMCID:
PMC9398112

PMID:
33737302

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Cancer Epidemiol Biomarkers Prev

Abbreviation: Cancer Epidemiol Biomarkers Prev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Abbreviated Score to Assess Adherence to the 2018 WCRF/AICR Cancer Prevention Recommendations and R…
Malcomson FC; Parra-Soto S; Ho FK and 3 more (2024) - Transparency Score: 3/6
A Population-Based Family Case-Control Study of Sun Exposure and Follicular Lymphoma Risk.
Odutola MK; van Leeuwen MT; Bruinsma F and 15 more (2024) - Transparency Score: 3/6
Choosing Wisely: Applying Value-Based Economic Principles to Population Science Research Investment.
Frick KD; Helzlsouer KJ. (2024) - Transparency Score: 3/6
Direct Medical Spending on Young and Average-Age Onset Colorectal Cancer before and after Diagnosis…
Garg R; Sayre EC; Pataky R and 7 more (2024) - Transparency Score: 3/6
Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies.
Li Y; Xiao X; Li J and 55 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Authors' Disclosures J. Pearson-Stuttard reports personal fees from Novo Nordisk A/S and Lane Clark & Peacock LLP, and is vice-chairman of the Royal Society for Public Health outside the submitted work. D. Gill reports other from Novo Nordisk outside the submitted work. No disclosures were reported by the other authors."

Evidence found in paper:

"No additional acknowledgements above authorship. No specific funding for this study. J. Pearson-Stuttard was supported by a National Institute for Health Research Academic Clinical Fellowship and now via the Wellcome Trust 4i Program at Imperial College London (203928/Z/16/Z)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025